ckd glp-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease GLP-1 receptor agonists and next-generation
Description
However, alternative glucose-lowering therapies are used adjunctively, but importantly are off-label in type 1 diabetes
Schedule your free consultation.
In the cohort analyses patients who initiated GLP-1 RAs did not differ in the hazard ratio (HR) for suicide or suicide attempts from SGLT-2 inhibitor users (HR: 0.93
Its a prescription drug with many uses, including treating type 2 diabetes in certain adults.
GLP-1 drugs are quickly becoming some of the most ubiquitous in the U.S., and they have drawn interest for their potential use in treating alcohol use disorder.
